Skip to content

Assessing the benefits of prescribed exercise in clinical populations

Prescribed exercise to enhance aerobic capacity and strength in clinical populations

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000389707
Enrollment
200
Registered
2013-04-10
Start date
2013-04-30
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the study is to compare the outcomes of individualised exercise programmes delivered in a “mixed environment” (a mix of closely supervised exercise in a “clinic-gym”, and exercise at home) with outcomes reported in controlled trials. No specific exclusion/inclusion criteria will be imposed. ADHB physicians and therapists will use their clinical judgment to identify patients they consider to be safe to exercise and will benefit from a well-designed and supervised 26-week exercise programme. With the participants’ consent, patient names and contact details will be provided to University of Auckland (UoA) researchers who will formally invite patients to enrol in the study. Researchers will follow American College of Sports Medicine guidelines during patient assessment, exercise prescription design, and exercise training. Standard fitness, strength and flexibility assessments will be made prior to, at 4-week intervals, and following the 26-week exercise programme. Participants will not be charged for the 26-week exercise programme. Qualified UoA clinical exercise physiologists will administer the exercise programmes. Postgraduate students will assist in the planning and delivery of exercise programmes, and data collected will be included in dissertations required to fulfil the academic and practical requirements for an MSc in Clinical Exercise Physiology.

Interventions

Evidence-based exercise prescription. 26-week programme. Individualised programme and session frequency to match fitness level, disabilities and co-morbidities (likely range: 3 x per week to once per week). Clinical-gym setting supervised by clinical exercise physiologists. Some programmes may include a home-based exercise component when deemed safe to conduct. Clinical exercise physiologists will monitor patient adherence via patient maintained log books and phone calls.

Sponsors

University of Auckland
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

Participants must be ambulatory and physician-approved to exercise. The following diagnoses will be included: Chronic kidney disease, cardiovascular disease, chronic obstructive pulmonary disease, stroke, Parkinson's disease, osteoarthritis, fibromyalgia, immune and blood diseases, post-breast and -colorectal cancer treatment.

Exclusion criteria

Inability to exercise; unstable cardiovascular or pulmonary condition.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026